South and Central America Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, and AndeXXa); End User (Hospital Pharmacies, Retail Pharmacies, and Others)

TIPRE00022215 | Pages: 124 | Pharmaceuticals | May 2021 | Type: Regional | Status: Published

Market Introduction

Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.

Thus, the increasing prevalence of stroke is expected to create a significant demand for anticoagulant reversal drugs in the coming years, which is further anticipated to drive the anticoagulant reversal drug market.

 


Get more information on this report :



Market Overview and Dynamics

The anticoagulant reversal drug market in South and Central America is expected to grow from US$ 29.8 million in 2019 to US$ 63.1 million by 2027; it is estimated to grow at a CAGR of 10.5% from 2019 to 2027. Various players operating in anticoagulant reversal drugs market are developing and launching new products to expand their geographic reach and capacity to cater a large number of customers. In April 2018, Boehringer Ingelheim, a leading pharmaceutical company, received the US Food and Drug Administration (FDA) full approval for Praxbind (idarucizumab), the specific reversal agent for Pradaxa (dabigatran etexilate mesylate). Similarly, in May 2018, Portola Pharmaceuticals received FDA approval for the rapid reversal of anticoagulation due to major bleeding. Such developments and approvals of new products are likely to favor the market growth.

 

Key Market Segments

In terms of product, the prothrombin complex concentrates segment accounted for the largest share of the South and Central America anticoagulant reversal drug market in 2019. In terms of distribution channel, the hospital pharmacies segment held a larger market share of the anticoagulant reversal drug market in 2019.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the anticoagulant reversal drug market in South and Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Boehringer Ingelheim International GmbH, Pfizer Inc, Octapharma AG, Fresenius Kabi AG, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), CSL Limited, and Grifols, S.A.

Reasons to buy report

  • To understand the South and Central America anticoagulant reversal drug market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for South and Central America anticoagulant reversal drug market
  • Efficiently plan M&A and partnership deals in South and Central America anticoagulant reversal drug market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South and Central America anticoagulant reversal drug market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in South and Central America region.


SOUTH AND CENTRAL AMERICA ANTICOAGULANT REVERSAL DRUG MARKET SEGMENTATION

By Product

  • Prothrombin Complex Concentrates
  • Vitamin K
  • Protamine
  • Tranexamic Acid
  • Idarucizumab
  • AndeXXa

 

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

 

By Country

  • South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America

 

 

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Pfizer Inc
  • Octapharma AG
  • Fresenius Kabi AG
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • CSL Limited
  • Grifols, S.A.

 

 

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Anticoagulant Reversal Drug Market – By Product

1.3.2        Anticoagulant Reversal Drug Market – By Distribution Channel

1.3.3        South and Central America Anticoagulant Reversal Drug Market – By Country

2.           South and Central America Anticoagulant Reversal Drug Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South and Central America Anticoagulant Reversal Drug Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Anticoagulant Reversal Drug Market- South and Central America PEST Analysis

4.3         Expert Opinion

5.           South and Central America Anticoagulant Reversal Drug Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Atrial Fibrillation (AFib)

5.1.2        Increase in Prevalence of Stroke

5.2         Market Restraints

5.2.1        High Cost of Anticoagulant Reversal Drugs

5.3         Market Opportunities

5.3.1        Increasing Research Activities on Anticoagulant Reversal Drugs

5.4         Future Trends

5.4.1        Development and Launch of Innovative Products

5.5         Impact Analysis

6.           Anticoagulant Reversal Drug Market – South and Central America Analysis

6.1         South and Central America Anticoagulant Reversal Drug Market Revenue Forecasts and Analysis

7.           South and Central America Anticoagulant Reversal Drug Market Analysis and Forecasts To 2027 – By Product

7.1         Overview

7.2         Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)

7.3         Prothrombin Complex Concentrates

7.3.1        Overview

7.3.2        Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.4         Vitamin K

7.4.1        Overview

7.4.2        Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.5         Protamine

7.5.1        Overview

7.5.2        Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.6         Tranexamic Acid

7.6.1        Overview

7.6.2        Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.7         Idarucizumab

7.7.1        Overview

7.7.2        Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.8         Andexxa

8.           South and Central America Anticoagulant Reversal Drug Market Analysis and Forecasts to 2027– By Distribution Channel

8.1         Overview

8.2         Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)

8.3         Hospital Pharmacies

8.3.1        Overview

8.3.2        Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.4         Retail Pharmacies

8.4.1        Overview

8.4.2        Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

9.           Anticoagulant Reversal Drug Market Revenue and Forecasts to 2027 – Geographical Analysis

9.1         South and Central America: Anticoagulant Reversal Drugs Market

9.1.1        Overview

9.1.2        South and Central America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)

9.1.3        Brazil: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          Brazil: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          Brazil: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.3.3          Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

9.1.4        Argentina: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.1          Argentina: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.2          Argentina: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.4.3          Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

9.1.5        Rest of South and Central America: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.1          Rest of South and Central America: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.2          Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.5.3          Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.        Impact Of COVID-19 Pandemic on South and Central America Anticoagulant Reversal Drug Market

10.1      South and Central America: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.2.2     Organic Developments Done By Companies

11.3      Inorganic Developments

11.3.1     Overview

11.3.2     Inorganic Developments Done By Companies

Source: The Insight Partners Analysis, Website, Press Releases and Others

12.        COMPANY PROFILES

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Pfizer Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Octapharma AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Fresenius Kabi AG

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6       Key Developments

12.5      Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      CSL Limited

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Grifols, S.A.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of Terms

 

LIST OF TABLES

Table 1.             Brazil: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 2.             Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 3.             Argentina: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027  (USD Million)

Table 4.             Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.             Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 6.             Rest of South and Central America: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7.             Glossary of Terms, Anticoagulant Reversal Drug Market

 

LIST OF FIGURES

Figure 1.           Anticoagulant Reversal Drug Market Segmentation

Figure 2.           South and Central America Anticoagulant Reversal Drug Market Overview

Figure 3.           Prothrombin Complex Concentrates Segment Held Largest Share of Product in Anticoagulant Reversal Drug Market

Figure 4.           Hospital Pharmacies Segment Held Largest Share of Distribution Channel in Anticoagulant Reversal Drug Market

Figure 5.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Anticoagulant Reversal Drug Market - South and Central America PEST Analysis

Figure 7.           Anticoagulant Reversal Drug Market Impact Analysis of Driver and Restraints

Figure 8.           South and Central America Anticoagulant Reversal Drug Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 1.           Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)

Figure 2.           Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 3.           Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 4.           Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 5.           Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 6.           Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 7.           Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 8.           Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 9.           Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 10.        Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 11.        South and Central America: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 12.        South and Central America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)

Figure 13.        Brazil: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 14.        Argentina: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 15.        Rest of South and Central America: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 16.        Impact of COVID-19 Pandemic in South and Central America Country Markets

Figure 17.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - South and Central America Anticoagulant Reversal Drug Market

  1. Boehringer Ingelheim International GmbH
  2. Pfizer Inc
  3. Octapharma AG
  4. Fresenius Kabi AG
  5. Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  6. CSL Limited
  7. Grifols, S.A.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America anticoagulant reversal drug market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America anticoagulant reversal drug market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the anticoagulant reversal drug market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000